Contipro A.s.

Contipro Pharma A.s.

Eva Prikopova

Vladimir Velebny

Kristina Nesporova

Gloria Huerta-Angeles

Jaromir Kulhanek

Daniela Smejkalova

Jaroslav Novotny

Miroslava Nemcova

Klara Slezingrova

Martina Hermannova

Lucie Vistejnova

Dagmar Cozikova

Martin Bobek

Jana Sogorkova

Jan Kucera

Pavel Klein

Martina Brandejsova

Zuzana Jouklova

Klara Slezingerova

Martina Moravcova

Jana Ruzickova

The invention relates to a method of preparation hydrophobized hyaluronic acid (Formula I) and further to a method of encapsulating biologically active substances into the nanomicelles of hydrophobized hyaluronan serving as carriers of biologically active hydrophobic substances. The hydrophobization of hyaluronan is carried out through an esterification reaction of hyaluronan with long-chain carboxylic acids, the latter being activated by a halogenide derivative of 2,4,6-trichlorobenzoic acid or by another organic chloride. In an aqueous environment, water-soluble hydrophobized derivatives can form nanomicelles in which nonpolar substances can be bound by means of non-covalent physical interactions. The core of a nanomicelle is formed by hydrophobic acyl functional groups while the shell of a nanomicelle is formed by hyaluronic acid. The encapsulation of the substances into nanomicelles can be performed by means of the solvent exchange method or by means of sonication. Hyaluronic nanomicelles support the penetration of bound substances in topical applications and enable the bound substances to be transferred into the individual cells. The nanomicelles obtained from hydrophobized hyaluronan derivatives are usable in cosmetic and pharmaceutical applications. 

[object Object]

Growing community of inventors

Techonin, Czechia

Eva Prikopova